MiMedx Statistics
Share Statistics
MiMedx has 147.37M
shares outstanding. The number of shares has increased by -0.16%
in one year.
| Shares Outstanding | 147.37M |
| Shares Change (YoY) | -0.16% |
| Shares Change (QoQ) | 0.29% |
| Owned by Institutions (%) | 68.64% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 143 |
| FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 4.84M, so 3.28% of the outstanding
shares have been sold short.
| Short Interest | 4.84M |
| Short % of Shares Out | 3.28% |
| Short % of Float | 4.1% |
| Short Ratio (days to cover) | 7.92 |
Valuation Ratios
The PE ratio is 33.33 and the forward
PE ratio is 17.57.
MiMedx's PEG ratio is
-0.84.
| PE Ratio | 33.33 |
| Forward PE | 17.57 |
| PS Ratio | 4.05 |
| Forward PS | 1.8 |
| PB Ratio | 7.32 |
| P/FCF Ratio | 21.92 |
| PEG Ratio | -0.84 |
Financial Ratio HistoryEnterprise Valuation
MiMedx has an Enterprise Value (EV) of 1.33B.
| EV / Sales | 3.81 |
| EV / EBITDA | 20.65 |
| EV / EBIT | 20.07 |
| EV / FCF | 20.59 |
Financial Position
The company has a current ratio of 4.21,
with a Debt / Equity ratio of 0.1.
| Current Ratio | 4.21 |
| Quick Ratio | 3.69 |
| Debt / Equity | 0.1 |
| Debt / EBITDA | 0.29 |
| Debt / FCF | 0.29 |
| Interest Coverage | 58.51 |
Financial Efficiency
Return on Equity is 21.97% and Return on Invested Capital is 19.67%.
| Return on Equity | 21.97% |
| Return on Assets | 16.07% |
| Return on Invested Capital | 19.67% |
| Revenue Per Employee | $416,820.79 |
| Profits Per Employee | $50,679.81 |
| Employee Count | 837 |
| Asset Turnover | 1.32 |
| Inventory Turnover | 2.52 |
Taxes
| Income Tax | 15.3M |
| Effective Tax Rate | 26.7% |
Stock Price Statistics
The stock price has increased by -7.01% in the
last 52 weeks. The beta is 1.85, so MiMedx's
price volatility has been higher than the market average.
| Beta | 1.85 |
| 52-Week Price Change | -7.01% |
| 50-Day Moving Average | 7.44 |
| 200-Day Moving Average | 7.52 |
| Relative Strength Index (RSI) | 41.04 |
| Average Volume (20 Days) | 622,202 |
Income Statement
In the last 12 months, MiMedx had revenue of 348.88M
and earned 42.42M
in profits. Earnings per share was 0.29.
| Revenue | 348.88M |
| Gross Profit | 288.81M |
| Operating Income | 58.87M |
| Net Income | 42.42M |
| EBITDA | 64.34M |
| EBIT | 58.3M |
| Earnings Per Share (EPS) | 0.29 |
Full Income StatementBalance Sheet
The company has 104.42M in cash and 18.83M in
debt, giving a net cash position of 85.59M.
| Cash & Cash Equivalents | 104.42M |
| Total Debt | 18.83M |
| Net Cash | 85.59M |
| Retained Earnings | -91.26M |
| Total Assets | 270.42M |
| Working Capital | 157.49M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 66.2M
and capital expenditures -1.68M, giving a free cash flow of 64.52M.
| Operating Cash Flow | 66.2M |
| Capital Expenditures | -1.68M |
| Free Cash Flow | 64.52M |
| FCF Per Share | 0.44 |
Full Cash Flow StatementMargins
Gross margin is 82.78%, with operating and profit margins of 16.87% and 12.16%.
| Gross Margin | 82.78% |
| Operating Margin | 16.87% |
| Pretax Margin | 16.42% |
| Profit Margin | 12.16% |
| EBITDA Margin | 18.44% |
| EBIT Margin | 16.87% |
| FCF Margin | 18.49% |
